Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Curry

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
Military Medicine|November 30, 2020
Transpacific Aeromedical Evacuation for a Ruptured Brain Arteriovenous Malformation During the COVID-19 PandemicDaniel S Ikeda, John R Dryden, Jan-Michael Van Gent, et al.
Journal of Orthopaedic Trauma|November 13, 2015
High Incidence of Undiagnosed Cervical Myelopathy in Patients With Hip Fracture Compared With ControlsKristen E Radcliff, Edward P Curry, Roman Trimba, et al.
WFUMB Ultrasound Open|May 26, 2025
Methods and Validation of Velacur Determined Fat Fraction in patients with MASLDMohammad Honarvar, Julio Lobo, Caitlin Schneider, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 28, 2021
Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic CholangiocarcinomaAmmar Sarwar, Aamir Ali, Damir Ljuboja, et al.
Alimentary Pharmacology & Therapeutics|July 11, 2017
Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patientsM P Curry, E B Tapper, B Bacon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2020
Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or CirrhosisEthan M Weinberg, Michael P Curry, Catherine T Frenette, et al.
Gastroenterology|July 5, 2016
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free RegimenMartina Gambato, Sofía Pérez-Del-Pulgar, Charlotte Hedskog, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated CirrhosisZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infectionKris V Kowdley, Vinay Sundaram, Christie Y Jeon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2010
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipientsC S Coffin, P G Stock, L M Dove, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Military Medicine|November 30, 2020
Transpacific Aeromedical Evacuation for a Ruptured Brain Arteriovenous Malformation During the COVID-19 PandemicDaniel S Ikeda, John R Dryden, Jan-Michael Van Gent, et al.
Journal of Orthopaedic Trauma|November 13, 2015
High Incidence of Undiagnosed Cervical Myelopathy in Patients With Hip Fracture Compared With ControlsKristen E Radcliff, Edward P Curry, Roman Trimba, et al.
WFUMB Ultrasound Open|May 26, 2025
Methods and Validation of Velacur Determined Fat Fraction in patients with MASLDMohammad Honarvar, Julio Lobo, Caitlin Schneider, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 28, 2021
Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic CholangiocarcinomaAmmar Sarwar, Aamir Ali, Damir Ljuboja, et al.
Alimentary Pharmacology & Therapeutics|July 11, 2017
Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patientsM P Curry, E B Tapper, B Bacon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2020
Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or CirrhosisEthan M Weinberg, Michael P Curry, Catherine T Frenette, et al.
Gastroenterology|July 5, 2016
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free RegimenMartina Gambato, Sofía Pérez-Del-Pulgar, Charlotte Hedskog, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated CirrhosisZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infectionKris V Kowdley, Vinay Sundaram, Christie Y Jeon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2010
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipientsC S Coffin, P G Stock, L M Dove, et al.
Pageof 21